Pulmonx Corp Stock Gross Profit
| LUNG Stock | USD 1.61 0.23 12.50% |
Fundamental analysis of Pulmonx Corp allows traders to better anticipate movements in Pulmonx Corp's stock price by examining its financial health and performance throughout various phases of its business cycle.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Pulmonx Corp Company Gross Profit Analysis
Pulmonx Corp's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Pulmonx Corp Gross Profit | 66.16 M |
Most of Pulmonx Corp's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pulmonx Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Pulmonx Corp reported 66.16 M of gross profit. This is 97.05% lower than that of the Health Care Equipment & Supplies sector and 95.9% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.76% higher than that of the company.
Pulmonx Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pulmonx Corp's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pulmonx Corp could also be used in its relative valuation, which is a method of valuing Pulmonx Corp by comparing valuation metrics of similar companies.Pulmonx Corp is currently under evaluation in gross profit category among its peers.
Pulmonx Fundamentals
| Return On Equity | -0.67 | ||||
| Return On Asset | -0.22 | ||||
| Profit Margin | (0.63) % | ||||
| Operating Margin | (0.62) % | ||||
| Current Valuation | 36.81 M | ||||
| Shares Outstanding | 40.26 M | ||||
| Shares Owned By Insiders | 4.40 % | ||||
| Shares Owned By Institutions | 92.12 % | ||||
| Number Of Shares Shorted | 1.44 M | ||||
| Price To Book | 0.93 X | ||||
| Price To Sales | 0.72 X | ||||
| Revenue | 83.79 M | ||||
| Gross Profit | 66.16 M | ||||
| EBITDA | (50.79 M) | ||||
| Net Income | (56.39 M) | ||||
| Cash And Equivalents | 162.09 M | ||||
| Cash Per Share | 4.35 X | ||||
| Total Debt | 56.47 M | ||||
| Debt To Equity | 0.15 % | ||||
| Current Ratio | 9.43 X | ||||
| Book Value Per Share | 1.71 X | ||||
| Cash Flow From Operations | (31.54 M) | ||||
| Short Ratio | 4.35 X | ||||
| Earnings Per Share | (1.43) X | ||||
| Price To Earnings To Growth | (0.42) X | ||||
| Target Price | 6.75 | ||||
| Number Of Employees | 291 | ||||
| Beta | 0.45 | ||||
| Market Capitalization | 64.81 M | ||||
| Total Asset | 162.85 M | ||||
| Retained Earnings | (467.56 M) | ||||
| Working Capital | 111.81 M | ||||
| Net Asset | 162.85 M |
About Pulmonx Corp Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pulmonx Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pulmonx Corp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pulmonx Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
| USOI | Credit Suisse X Links | |
| ULTY | Tidal Trust II | |
| CONY | YieldMax N Option | |
| BCAT | BlackRock Capital Allocation | |
| PDI | Pimco Dynamic Income |
Check out Pulmonx Corp Piotroski F Score and Pulmonx Corp Altman Z Score analysis. For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.